Effect of timing of casirivimab and imdevimab administration relative to mRNA-1273 COVID-19 vaccination on vaccine-induced SARS-CoV-2 neutralising antibody responses: a prospective, open-label, phase 2, randomised controlled trial
Titel:
Effect of timing of casirivimab and imdevimab administration relative to mRNA-1273 COVID-19 vaccination on vaccine-induced SARS-CoV-2 neutralising antibody responses: a prospective, open-label, phase 2, randomised controlled trial
Auteur:
Isa, Flonza Gonzalez Ortiz, Ana M Meyer, Jonathan Hamilton, Jennifer D Olenchock, Benjamin A Brackin, Taylor Ganguly, Samit Forleo-Neto, Eduardo Faria, Lori Heirman, Ingeborg Marovich, Mary Hutter, Julia Polakowski, Laura Irvin, Susan C Thakur, Mazhar Hooper, Andrea T Baum, Alina Petro, Christopher D Fakih, Faisal A McElrath, M Juliana De Rosa, Stephen C Cohen, Kristen W Williams, LaTonya D Hellman, Caleb A Odeh, Ahmad J Patel, Aloki H Tomaras, Georgia D Geba, Gregory P Kyratsous, Christos A Musser, Bret Yancopoulos, George D Herman, Gary A